Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Lymphokines – e.g. – interferons – interlukins – etc.
Reexamination Certificate
2004-02-26
2009-02-17
Saoud, Christine J (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Lymphokines, e.g., interferons, interlukins, etc.
C530S350000, C424S185100
Reexamination Certificate
active
07491800
ABSTRACT:
The present invention relates to zalpha11 Ligand polynucleotide and polypeptide molecules. The zalpha11 Ligand is a novel cytokine. The polypeptides may be used within methods for stimulating the proliferation and/or development of hematopoietic cells in vitro and in vivo. The present invention also includes methods for producing the protein, uses therefor and antibodies thereto.
REFERENCES:
patent: 5573924 (1996-11-01), Beckmann et al.
patent: 6057128 (2000-05-01), Donaldson et al.
patent: 6307024 (2001-10-01), Novak et al.
patent: 6605272 (2003-08-01), Dillon et al.
patent: 6686178 (2004-02-01), Dillon et al.
patent: 6929932 (2005-08-01), Presnell et al.
patent: 2004/0009150 (2004-01-01), Nelson et al.
patent: 2004/0110932 (2004-06-01), Novak et al.
patent: 2005/0095223 (2005-05-01), Sivakumar et al.
patent: 2005/0244930 (2005-11-01), Presnell et al.
patent: 2005/0265966 (2005-12-01), Kindsvogel et al.
patent: 2006/0134754 (2006-06-01), Chan et al.
patent: 99/61617 (1999-12-01), None
patent: 2004/032857 (2004-04-01), None
patent: 2004/112703 (2004-12-01), None
patent: 2005/037306 (2005-04-01), None
Ngo et al., Computational Complexity, Protein Structure Prediction, and Levinthal Paradox, 1994, The Protein Folding Problem and Tertiary Structure Prediction, pp. 492-495.
Wells, Aditivity of Mutational Effects in Proteins, 1990, Biochemistry, vol. 26, No. 37, pp. 8509-8517.
U.S. Appl. No. 10/456,262, filed Jun. 6, 2003, Nelson et al.
U.S. Appl. No. 11/285,970, filed Nov. 23, 2005, Yee.
U.S. Appl. No. 11/346,580, filed Feb. 2, 2006, Novak et al.
Hill et al., “Cytokines: promoters and dampeners of autoimmunity,”Current Opinion in Immunology, Current Biology LTD14(6):791-797, 2002.
Clegg et al., “Therapeutic Opportunities for IL-21,”European Cytokine Networkvol. 14, No. Supplement 3, 2003.
Nelson, et al., “Interleukin 2t has anti-tumor activity in animal models without the toxicity of IL-2,”Procedures of the American Association for Cancer Research Annual Meeting, vol. 44, Jul. 2003.
Funaro et al., “Monoclonal antibodies and therapy of human cancers,”Biotechnology Advances, Elsevier Publishing Barking, GB vol. 18 No. 5, 2000.
Parrish-Novak et al.,Nature408: 57-63, 2000.
Dillon Stacey R.
Foster Donald C.
Gross Jane A.
Hammond Angela K.
Holly Richard D.
Saoud Christine J
Sawislak Deborah A.
Seharaseyon Jegatheesan
ZymoGenetics Inc.
LandOfFree
Cytokine zalpha11 ligand fusion proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cytokine zalpha11 ligand fusion proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cytokine zalpha11 ligand fusion proteins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4135446